Ticker · CUSIP 31189P102

FATE

FATE THERAPEUTICS INC
···Share
Holders (tracked)
8
Combined shares
8,144,559
Combined value
$8.00M
Last close
$1.39
Quarter
2025Q4
Price · 1Y$1.39+0.28 (+25.23%)H $1.67 · L $0.92 · Avg Vol 1.8M
$1.00$1.20$1.40$1.60VolJul 25Oct 25Jan 26Apr 26
Tracked holders · last 8 quarters
Flat over the last 8 quarters.
8102024Q12025Q4
Price is +41.5% vs the avg quarter-end implied price across tracked holders.

SEC event timeline

11 events
  1. +30,591 shares · 2025Q4
    Position
  2. +833,307 shares · 2025Q4
    Position
  3. −75,209 shares · 2025Q4
    Position
  4. −441,254 shares · 2025Q4
    Position
  5. +1,527,986 shares · 2025Q4
    Position
  6. +1,098,366 shares · 2025Q4
    Position
  7. +285,181 shares · 2025Q3
    Position
  8. +84,183 shares · 2025Q3
    Position
  9. +672,352 shares · 2025Q3
    Position
  10. +7,615 shares · 2025Q3
    Position
  11. +1,048,052 shares · 2025Q3
    Position

Insider activity

No insider transactions in the last 30 days.
Follow-the-investor returns
If you'd copied each holder of FATE…
Cost basis inferred from each manager's quarter-over-quarter position changes. Sorted by % return on the position they're still holding.
InvestorFirst inCost basisReturnPosition value today
Ken Griffin (Citadel Advisors)2017Q1$0.99+40.6%$1.0M
Ken Griffin (Citadel Advisors)2017Q1$0.99+40.6%$1.0M
AQR Capital Management2018Q1$1.17+19.1%$1.6M
Izzy Englander (Millennium Mgmt)2016Q1$1.48-5.9%$726K
Renaissance Technologies2016Q1$1.49-7.0%$3.3M
Two Sigma Investments2016Q1$1.64-15.4%$2.4M
Steve Cohen (Point72)2019Q1$3.75-62.9%$2.1M
T. Rowe Price2017Q4$11.08-87.5%$76K

Who moved on this name in 2025Q4

Position changes reported for the latest quarter, grouped by direction.
New positions1
Added to3
Exited0

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2022Q1
13
$22.61B
2022Q2
11
$18.09B
2022Q3
13
$579.2M
2022Q4
13
$256.0M
2023Q1
13
$135.6M
2023Q2
12
$111.5M
2023Q3
13
$52.0M
2023Q4
10
$75.4M
2024Q1
10
$106.4M
2024Q2
12
$68.6M
2024Q3
11
$31.3M
2024Q4
9
$11.9M
2025Q1
8
$4.7M
2025Q2
8
$7.7M
2025Q3
8
$6.5M
2025Q4
8
$8.0M

Who owns FATE

8 super-investors · 2025Q4
Tracked stake
8.14M
shares
Combined value
$8M
% of shares outstanding
shares-out unknown
Quarter action mix
New1Added3Trim3Held1
#ManagerSharesValue
1Renaissance Technologies2.36M$2M
2Two Sigma Investments1.73M$2M
3Steve Cohen
Point72
1.53M$2M
4AQR Capital Management1.16M$1M
5Ken Griffin
Citadel Advisors
749.3K$736K
6Izzy Englander
Millennium Mgmt
522.6K$514K
7T. Rowe Price54.5K$54K
8Ken Griffin
Citadel Advisors
33.2K$33K

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live FATE chart.
<iframe src="https://openstocks.me/embed/stock/FATE" width="100%" height="480" frameborder="0" loading="lazy" title="FATE chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>